Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 14, 2010European Respiratory JournalOpen Access

Clinical management of tuberculosis and HIV-1 co-infection

View Full Paper
Ask AI
Bookmark
Share

Authors

CSCharlotte SchutzUniversity of Cape TownGMGraeme MeintjesUniversity of Cape TownFAFahad AlmajidDubai Health Authority

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schutz et al. (2010) studied this question.

synapsesocial.com/papers/6a237e4e55bd20cf6fa5e316https://doi.org/10.1183/09031936.00110210
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets2008 · 114 citations
  2. 2Effect of HIV-1 Infection on T-Cell–based and Skin Test Detection of Tuberculosis Infection2006 · 216 citations
  3. 3Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country2008 · 106 citations
  4. 4Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults2001 · 156 citations
  5. 5Management of tuberculosis in HIV infection: where T-cells matter2010 · 9 citations